Management of cancer-associated disseminated intravascular coagulation

Thrombosis Research

Volumn 140, Issue , 2016, Pages S66-S70

  Levi, Marcel ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Coagulation; Disseminated intravascular coagulation; Fibrinolysis; Thrombotic microangiopathy; Tissue factor

Indexed keywords

ARTICLE; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; EXHAUSTION; HUMAN; MICROANGIOPATHY; NEOPLASM; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM; BLOOD; BLOOD CLOTTING; COMPLICATION; DISEASE MANAGEMENT; DISSEMINATED INTRAVASCULAR COAGULATION; DRUG EFFECTS; PATHOLOGY;

ANTICOAGULANT AGENT;

ANTICOAGULANTS; BLOOD COAGULATION; DISEASE MANAGEMENT; DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; NEOPLASMS; THROMBOTIC MICROANGIOPATHIES;

EID: 84962687552     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(16)30101-3     Document Type: Article

References (64)

1. M. Levi Cancer-related coagulopathies Thromb Res. 133 Suppl 2 2014 S70 S75
2. M. Levi Disseminated intravascular coagulation in cancer patients Best Pract Res Clin Haematol 22 1 2009 129 136
3. H.C. Kwaan, and L.I. Gordon Thrombotic microangiopathy in the cancer patient Acta Haematol 106 1-2 2001 52 56
4. M. Levi Cancer and thrombosis Clin Adv Hematol Oncol 1 11 2003 668 671
5. S. Sallah, J.Y. Wan, N.P. Nguyen, L.R. Hanrahan, and G. Sigounas Disseminated intravascular coagulation in solid tumors: clinical and pathological study Thromb Haemost. 86 2001 828 833
6. T. Barbui, and A. Falanga Disseminated intravascular coagulation in acute leukemia Semin Thromb Hemost 27 6 2001 593 604
7. A.H. Sarris, S. Kempin, E. Berman, J. Michaeli, C. Little, M. Andreeff, and et al. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia Blood 79 5 1992 1305 1310
8. G. Avvisati, J.W. ten Cate, A. Sturk, R. Lamping, M.G. Petti, and F. Mandelli Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia British Journal of Haematology 70 1 1988 43 48
9. A. Falanga Mechanisms of hypercoagulation in malignancy and during chemotherapy Haemostasis. 28 Suppl 3 1998 50 60
10. M.S. Tallman The thrombophilic state in acute promyelocytic leukemia Seminars in Thrombosis & Hemostasis 25 2 1999 209 215
11. F. Rodeghiero, and G. Castaman The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia Leukemia 8 Suppl 2 1994 S20 S26 [Review] [65 refs]
12. M.B. Donati Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice Thrombosis & Haemostasis 74 1 1995 278 281
13. J. Contrino, G. Hair, D.L. Kreutzer, and F.R. Rickles In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease Nature Medicine 2 2 1996 209 215
14. F.R. Rickles, and B. Brenner Tissue factor and cancer Semin Thromb Hemost 34 2 2008 143 145
15. M.E. Bromberg, W.H. Konigsberg, J.F. Madison, A. Pawashe, and A. Garen Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation Proceedings of the National Academy of Sciences of the United States of America 92 18 1995 8205 8209
16. Y. Zhang, Y. Deng, T. Luther, M. Muller, R. Ziegler, R. Waldherr, and et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice Journal of Clinical Investigation 94 3 1994 1320 1327
17. Y. Nadir, I. Vlodavsky, and B. Brenner Heparanase, tissue factor, and cancer Semin Thromb Hemost 34 2 2008 187 194
18. C. Milsom, J. Yu, L. May, N. Magnus, and J. Rak Diverse roles of tissue factor-expressing cell subsets in tumor progression Semin Thromb Hemost 34 2 2008 170 181
19. M. Ishibashi, N. Ito, M. Fujita, H. Furue, and T. Yamaji Endothelin-1 as an aggravating factor of disseminated intravascular coagulation associated with malignant neoplasms Cancer 73 1 1994 191 195
20. M. Zangari, E. Anaissie, B. Barlogie, A. Badros, R. Desikan, A.V. Gopal, and et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy Blood 98 5 2001 1614 1615
21. A.A. Desai, N.J. Vogelzang, B.I. Rini, R. Ansari, S. Krauss, and W.M. Stadler A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma Cancer 95 8 2002 1629 1636
22. B.C. Kuenen, L. Rosen, E.F. Smit, M.R. Parson, M. Levi, R. Ruijter, and et al. Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors J Clin Oncol 20 6 2002 1657 1667
23. R.D. Bona Thrombotic complications of central venous catheters in cancer patients Semin Thromb Hemost 25 2 1999 147 155
24. L.J. Walshe, S.F. Malak, J. Eagan, and K.A. Sepkowitz Complication rates among cancer patients with peripherally inserted central catheters J Clin Oncol 20 15 2002 3276 3281
25. T.M. Niers, N.M. Di, C.P. Klerk, H.J. Baarslag, H.R. Buller, and B.J. Biemond Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study J Thromb Haemost 5 9 2007 1878 1882
26. S. van Wissen, B.A. Bastiaansen, A.K. Stroobants, E.J. van den Dool, M.M. Idu, M. Levi, and et al. Catastrophic antiphospholipid syndrome mimicking a malignant pancreatic tumour - a case report Lupus 17 6 2008 586 590
27. D.C. Doll, and J.W. Yarbro Vascular toxicity associated with antineoplastic agents Semin Oncol 19 5 1992 580 596
28. A.R. Pettitt, and R.E. Clark Thrombotic microangiopathy following bone marrow transplantation Bone Marrow Transplant 14 4 1994 495 504
29. H.W. Snyder Jr., A. Mittelman, A. Oral, G.L. Messerschmidt, D.H. Henry, S. Korec, and et al. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma Cancer 71 5 1993 1882 1892
30. E.C. Guinan, N.J. Tarbell, C.M. Niemeyer, S.E. Sallan, and H.J. Weinstein Intravascular hemolysis and renal insufficiency after bone marrow transplantation Blood 72 2 1988 451 455
31. M.E. Chappell, D.M. Keeling, H.G. Prentice, and P. Sweny Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? Bone Marrow Transplant 3 4 1988 339 347
32. C. Antignac, M.C. Gubler, G. Leverger, M. Broyer, and R. Habib Delayed renal failure with extensive mesangiolysis following bone marrow transplantation Kidney Int 35 6 1989 1336 1344
33. S.N. Rabinowe, R.J. Soiffer, N.J. Tarbell, D. Neuberg, A.S. Freedman, J. Seifter, and et al. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies Blood 77 8 1991 1837 1844
34. A.M. Jackson, B.D. Rose, L.G. Graff, J.B. Jacobs, J.H. Schwartz, G.M. Strauss, and et al. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy Ann Intern Med 101 1 1984 41 44
35. E. Holler, H.J. Kolb, E. Hiller, W. Mraz, W. Lehmacher, B. Gleixner, and et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation Blood 73 7 1989 2018 2024
36. P.W. Collins, C.N. Gutteridge, A. O'Driscoll, S. Blair, L. Jones, R. Aitchison, and et al. von Willebrand factor as a marker of endothelial cell activation following BMT Bone Marrow Transplant 10 6 1992 499 506
37. M.C. Bertomeu, S. Gallo, D. Lauri, M.N. Levine, F.W. Orr, and M.R. Buchanan Chemotherapy enhances endothelial cell reactivity to platelets Clin Exp Metastasis 8 6 1990 511 518
38. E.M. Conway, M. Van de Weerd, S. Pollefeyt, K. Jurk, H. Van Aken, A. De Vriese, and et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways J Exp Med 196 5 2002 565 577
39. M. Levi, J.W. ten Cate, G. Dooijewaard, A. Sturk, E.J. Brommer, and G. Agnelli DDAVP induces systemic release of urokinase-type plasminogen activator Thrombosis & Haemostasis 62 2 1989 686 689
40. M. Levi, H. ten Cate, and T. van der Poll Endothelium: interface between coagulation and inflammation Crit Care Med 30 5 Suppl 2002 S220 S224
41. C. Seeber, E. Hiller, E. Holler, and H.J. Kolb Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT) Thromb Res 66 4 1992 373 383
42. H. Cohen, H.A. Bull, A. Seddon, M.S. Enayat, F.G. Hill, N. Woolf, and et al. Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation Eur J Haematol 43 3 1989 207 214
43. D. Charba, J.L. Moake, M.A. Harris, and J.P. Hester Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies Am J Hematol 42 3 1993 268 277
44. M. Franchini, M. Montagnana, G. Targher, and G. Lippi Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases Semin Thromb Hemost 33 8 2007 787 797
45. S.A. Gregory, J.H. Morrissey, and T.S. Edgington Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin Mol Cell Biol 9 6 1989 2752 2755
46. T. Koyama, K. Nishida, S. Ohdama, M. Sawada, N. Murakami, S. Hirosawa, and et al. Determination of plasma tissue factor antigen and its clinical significance Br J Haematol 87 2 1994 343 347
47. E.M. Conway, and R.D. Rosenberg Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells Molecular & Cellular Biology 8 12 1988 5588 5592
48. D. Collen On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture Thrombosis & Haemostasis 43 2 1980 77 89
49. M. Levi, T. van der Poll, H. ten Cate, and S.J. van Deventer The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia European Journal of Clinical Investigation 27 1 1997 3 9
50. H. Wada, T. Kaneko, M. Ohiwa, M. Tanigawa, T. Hayashi, S. Tamaki, and et al. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura Am J Hematol 44 2 1993 101 105
51. J. Thachil, A. Falanga, M. Levi, H. Liebman, and M. Di Nisio Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH J Thromb Haemost 13 4 2015 671 675
52. J.J. Corrigan Jr., and C.M. Jordan Heparin therapy in septicemia with disseminated intravascular coagulation New England Journal of Medicine 283 15 1970 778 782
53. G. Audibert, H. Lambert, F. Toulemonde, P. Alexandre, M.C. Laprevote-Heully, P.E. Bollaert, and et al. Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy Journal des Maladies Vasculaires 12 Suppl B 1987 147 151
54. D.I. Feinstein Treatment of disseminated intravascular coagulation Seminars in Thrombosis & Hemostasis 14 4 1988 351 362
55. D.J. Cook, M.A. Crowther, M.O. Meade, and J. Douketis Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients J Crit Care 20 4 2005 309 313
56. R. Patel, D.J. Cook, M.O. Meade, L.E. Griffith, G. Mehta, G.M. Rocker, and et al. Burden of illness in venous thromboembolism in critical care: a multicenter observational study J Crit Care 20 4 2005 341 347
57. M.M. Samama, A.T. Cohen, J.Y. Darmon, L. Desjardins, A. Eldor, C. Janbon, and et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group N Engl J Med 341 11 1999 793 800
58. M. Levi, and S.M. Opal Coagulation abnormalities in critically ill patients Crit Care 10 4 2006 222
59. G.R. Bernard, J.L. Vincent, P.F. Laterre, S.P. LaRosa, J.F. Dhainaut, A. Lopez-Rodriguez, and et al. Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 10 2001 699 709
60. P.M. Mannucci, and M. Levi Prevention and treatment of major blood loss N Engl J Med 356 22 2007 2301 2311
61. G. Avvisati, J.W. ten Cate, H.R. Buller, and F. Mandelli Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia Lancet 2 8655 1989 122 124
62. M.J. Wheater, G.M. Mead, S. Bhandari, and J. Fennell Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma J Clin Oncol 26 6 2008 1008 1010
63. A. Shenoy, B.N. Savani, and A.J. Barrett Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation Biol Blood Marrow Transplant 13 5 2007 622 623
64. A.A. Erikci, A. Ozturk, and O. Sayan Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia Blood Coagul Fibrinolysis 17 4 2006 323 324